Skip to main content
. 2021 Oct 13;12:754565. doi: 10.3389/fendo.2021.754565

Table 5.

Basal procalcitonin (proCt) and stimulated proCt accuracies in the identification of medullary thyroid cancer (MTC) patients in our series.

Basal proCt
≤0.07 ng/ml >0.07 ng/ml
Non-MTC (N) 87 1 88 Sensitivity (%) 85.7
MTC (N) 9 54 63 Specificity (%) 98.9
Total (N) 96 55 151 PPV (%) 98.2
NPV (%) 90.6
Stimulated proCt
≤0.19 ng/ml >0.19 ng/ml
Non-MTC (N) 13 0 13 Sensitivity (%) 90.0
MTC (N) 2 18 20 Specificity (%) 100.0
Total (N) 15 18 33 PPV (%) 100.0
NPV (%) 86.7